Abstract:Background: As a class of promising bone augmentation materials, bone cements have attracted particular attention. Due to various limitations, the current bone cements are still imperfect. In this study, an injectable pH neutral bioactive bone cement (PSC/CSC) was developed by mixing phosphosilicate bioactive glass (PSC) and α-calcium sulfate hemihydrate (CSH), with the goal of optimizing bone defects repairs. Methods: A range of compositions (PSC/CSC: 10P/90C, 30P/70C, 50P/50C) were developed and their physicochemical properties evaluated. Their bone regeneration ability was compared to those of two widely used bone cements as controls (calcium phosphate cement (CPC) and Genex®) in rabbit femoral condyle bone defect models for 4, 8 and 12 weeks. Based on physicochemical properties and in vivo bone regeneration ability, the PSC/CSC exhibited the best outcomes was selected. Then, in vitro, the effects of selected PSC/CSC, CPC and Genex® extracts on MC3T3-E1 cell proliferation, migration and osteogenesis as well as angiogenesis of HUVECs were examined. Results: Based on physicochemical properties, the 30P/70C formula exhibited suitable operability and compressive strength (3.5 ± 0.3 MPa), which fulfilled the requirements for cancellous bone substitutes. In vivo, findings from micro-CT and histological analyses showed that the 30P/70C formula better promoted bone regeneration, compared to 10P/90C, 50P/50C, CPC and Genex®. Hence, 30P/70C was selected as the ideal PSC-based cement. In vitro, the 30P/70C extracts showed better promotion of cell viability, alkaline phosphatase (ALP) activity, calcium mineral deposition, mRNA and protein expression levels of osteogenesis in MC3T3-E1 cells, further supporting its superiority. Meanwhile, the 30P/70C extracts also showed better stimulation of HUVECs proliferation and angiogenesis. Conclusion: The new composite cement, 30P/70C, is a favorable bioactive glass-based bone cement with suitable operability, compressive strength and bone regeneration ability. The translational potential of this article: Clinically, treatment of large bone defects is still a major challenge for orthopaedic trauma. We showed that 30P/70C has the potential to be clinically used as an injectable cement for rapid bone repairs and reconstruction of critical sized bone defects.

Pregelatinized hydroxypropyl distarch phosphate reinforced calcium sulfate bone cement for bleeding bone treatment

Novel Bone Wax Based on DCPA Granules and Modified Starch for Hemostasis and Bone Regeneration

A Bioactive Degradable Composite Bone Cement Based on Calcium Sulfate and Magnesium Polyphosphate

An injectable pH neutral bioactive glass-based bone cement with suitable bone regeneration ability

Biodegradable composite scaffolds of bioactive glass/chitosan/carboxymethyl cellulose for hemostatic and bone regeneration

Calcium sulfate:A new application as a mixture with other bone graft materials

Calcium Ion-Coupled Polyphosphates with Different Degrees of Polymerization for Bleeding Control

Injectable pregelatinized corn starch reinforced calcium sulfate cement for bone defect repair

A ternary calcium silicate bone cement with high mechanical properties and good operability

Development of Injectable Calcium Sulfate and Self-Setting Calcium Phosphate Composite Bone Graft Materials for Minimally Invasive Surgery

A Promising Material for Bone Repair: PMMA Bone Cement Modified by Dopamine-Coated Strontium-Doped Calcium Polyphosphate Particles

Improved Bone Ingrowth of Tricalcium Phosphate Filled Poly(methyl Methacrylate) (PMMA) Bone Cements in Vivo

Noncompressible Hemostasis and Bone Regeneration Induced by an Absorbable Bioadhesive Self‐Healing Hydrogel

Polyacrylic acid-reinforced organic-inorganic composite bone adhesives with enhanced mechanical properties and controlled degradability

Injectable, Non‐Diffusible, and Pre‐Filled Bone Paste Composed of α‐Tricalcium Phosphate and Hydrophobically Modified Poly(Vinyl Alcohol)

Reinforcement of Calcium Phosphate Cement Using Alkaline-Treated Silk Fibroin.

Development of Novel Polyanhydride/Nanoceramics Composite Bone Grafts with Suitable Mechanical Strength and Long Durability

Hydrophilic competent and enhanced wet-bond strength castor oil-based bioadhesive for bone repair

Degradable and Bioadhesive Alginate-Based Composites: an Effective Hemostatic Agent

Development of paste-like organic/inorganic artificial bones compatible with bone remodeling cycles, consisting of β-tricalcium phosphate, calcium sulfate hemihydrate, and poly(lactic-co-glycolic acid) particles

A novel strategy for calcium magnesium phosphate/carboxymethyl chitosan composite bone cements with enhanced physicochemical properties, excellent cytocompatibility and osteogenic differentiation